Elisabet Cuyàs

15PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 17, 2026
Fatty acid synthesis therapy-induced senescence (FASTIS) in cancer cells.

|Feb 19, 2026
Mitochondrial bioenergetics-SASP crosstalk determines senolytic efficacy in therapy-induced senescence.

Àngela Llop-Hernández, Sara Verdura, Júlia López

|Mar 07, 2025
Mitochondrial priming and response to BH3 mimetics in "one-two punch" senogenic-senolytic strategies.

Júlia López, Àngela Llop-Hernández, Sara Verdura

|Sep 30, 2024
Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity.

Elisabet Cuyàs, Stefano Pedarra, Sara Verdura

|Dec 23, 2022
Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells.

Elisabet Cuyàs, Salvador Fernández-Arroyo, Sara Verdura

|Dec 23, 2022
Silibinin Overcomes EMT-Driven Lung Cancer Resistance to New-Generation ALK Inhibitors.

Sara Verdura, Jose Antonio Encinar, Eduard Teixidor

Pageof 3

Frequent Collaborators

14 joint publications

Javier A Menendez

9 joint publications

Sara Verdura

6 joint publications

Joaquim Bosch-Barrera

4 joint publications

Ruth Lupu